EN
The ability of COVID-19 patients' blood to coagulate after withdrawn to EDTA tube: A case report
Abstract
In the same family, the SARS-COV-2 virus is more virulent than the other virus, and it is known in many patients that it causes extreme symptoms ranging from high-grade fever, cough, dyspnea, to gastrointestinal and hematological symptoms.
The extreme inflammatory state secondary to Covid‐19 may lead to a severe imbalance in hemostasis as found recently in a condition of disseminated intravascular coagulation (DIC) and consumption coagulopathy, identified as decreased platelet count, increased fibrin or fibrinogen and red blood cells destruction which growing ferritin.
The virus has the ability to cause red blood cell hemolysis even if the blood is inside the EDTA tube, which reflects the virulent traits of the virus and its non-understandable pathogenesis, which is still suspected.
The damage caused by the tissue may increase the level of lactic acid dehydrogenase and may be an indicator of the amount of damage caused by the disease in the organs of the body.
Keywords
Kaynakça
- Hassan S, Sheikh F, Jamal S, Ezeh J, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2020;.
- Giannis D, Ziogas I, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology. 2020;127:104362.
- Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V et al. Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. Journal of Thrombosis and Haemostasis. 2020;.
- Jose R, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. The Lancet Respiratory Medicine. 2020;8(6):e46-e47.
- Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M et al. The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. Journal of Thrombosis and Haemostasis. 2020;.
- Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thrombosis and Haemostasis. 2020;120(06):998-1000.
- Connors J, Levy J. Thromboinflammation and the hypercoagulability of COVID‐19. Journal of Thrombosis and Haemostasis. 2020;.
- Levi M, Thachil J, Iba T, Levy J. Coagulation abnormalities and thrombosis in patients with COVID-19. The Lancet Haematology. 2020;7(6):e438-e440.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Olgu Sunumu
Yazarlar
Yayımlanma Tarihi
31 Aralık 2020
Gönderilme Tarihi
21 Temmuz 2020
Kabul Tarihi
8 Aralık 2020
Yayımlandığı Sayı
Yıl 1970 Cilt: 42 Sayı: 4